Assessment of pelvic lymph node micrometastatic disease in stages IB and IIA of carcinoma of the uterine cervix

International Journal of Gynecological Cancer

Volumn 16, Issue 3, 2006, Pages 1188-1194

  Fregnani, J H T G ^a   Latorre, M R D O ^b   Novik, P R ^c   Lopes, A ^c   Soares, F A ^c  

^a FACULDADE DE CIÊNCIAS MÉDICAS DA SANTA CASA DE SÃO PAULO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c A C CAMARGO CANCER CENTER   (Brazil)

Author keywords

Carcinoma of the uterine cervix; Lymph node; Micrometastases; Prognosis

Indexed keywords

ARTICLE; CANCER ADJUVANT THERAPY; CANCER CLASSIFICATION; CANCER INFILTRATION; CANCER INVASION; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DISEASE SEVERITY; FEMALE; HAZARD ASSESSMENT; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY INFILTRATE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MEDICAL ASSESSMENT; MICROMETASTASIS; PELVIS LYMPH NODE; PRIORITY JOURNAL; RISK ASSESSMENT; SURVIVAL RATE; SURVIVAL TIME; TISSUE SECTION; UTERINE CERVIX CARCINOMA;

CARCINOMA; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KERATINS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PELVIS; RISK FACTORS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS;

EID: 33745101986     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2006.00519.x     Document Type: Article

References (31)

1. Wang CJ Lai CH Huang HJ et al. Recurrent cervical carcinoma after primary radical surgery. Am J Obstet Gynecol 1999 181: 518 24.
2. Benedet JL Odicino F Maisonneuve P et al. FIGO (International Federation of Gynecology and Obstetrics) annual report on the results of treatment in gynecological cancer. Int J Gynaecol Obstet 2003 83 ( Suppl. 1 ix xxii, 1 229.
3. Singh N Arif S. Histopathologic parameters of prognosis in cervical cancer - a review. Int J Gynecol Cancer 2004 14: 741 50.
4. Inoue T Morita K. The prognostic significance of number of positive nodes in cervical carcinoma stages IB, IIA, and IIB. Cancer 1990 65: 1923 7.
5. Tsai CS Lai CH Wang CC et al. The prognostic factors for patients with early cervical cancer treated by radical hysterectomy and postoperative radiotherapy. Gynecol Oncol 1999 75: 328 33.
6. Aoki Y Sasaki M Watanabe M et al. High-risk group in node-positive patients with stage IB, IIA, and IIB cervical carcinoma after radical hysterectomy and postoperative pelvic irradiation. Gynecol Oncol 2000 77: 305 9.
7. Inoue T Chihara T Morita K. The prognostic significance of the size of the largest nodes in metastatic carcinoma from the uterine cervix. Gynecol Oncol 1984 19: 187 93.
8. Lin HH Cheng WF Chan KW Chang DY Chen CK Huang SC. Risk factors for recurrence in patients with stage IB, IIA, and IIB cervical carcinoma after radical hysterectomy and postoperative pelvic irradiation. Obstet Gynecol 1996 88: 274 9.
9. Van Trappen PO Gyselman VG Lowe DG et al. Molecular quantification and mapping of lymph-node micrometastases in cervical cancer. Lancet 2001 357: 15 20.
10. Juretzka MM Jensen KC Longacre TA Teng NN Husain A. Detection of pelvic lymph node micrometastasis in stage IA2-IB2 cervical cancer by immunohistochemical analysis. Gynecol Oncol 2004 93: 107 11.
11. Lentz SE Muderspach LI Felix JC Ye W Groshen S Amezcua CA. Identification of micrometastases in histologically negative lymph nodes of early-stage cervical cancer patients. Obstet Gynecol 2004 103: 1204 10.
12. Marchiole P Buenerd A Benchaib M Nezhat K Dargent D Mathevet P. Clinical significance of lymphovascular space involvement and lymph node micrometastases in early-stage cervical cancer: a retrospective case-control surgico-pathological study. Gynecol Oncol 2005 97: 727 32.
13. Piver MS Rutledge F Smith JP. Five classes of extended hysterectomy for women with cervical cancer. Obstet Gynecol 1974 44: 265 72.
14. Hermanek P Hutter RV Sobin LH Wittekind C. International Union Against Cancer. Classification of isolated tumor cells and micrometastasis. Cancer 1999 86: 2668 73.
15. Reich O Tamussino K Haas J Winter R. Benign müllerian inclusions in pelvic and para-aortic lymph nodes. Gynecol Oncol 2000 78: 242 4.
16. Dowlatshahi K Fan M Snider HC Habib FA. Lymph node micrometastases from breast carcinoma: reviewing the dilemma. Cancer 1997 80: 1188 97.
17. Balch CM Soong SJ Gershenwald JE et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 2001 19: 3622 34.
18. Blaheta HJ Schittek B Breuninger H Garbe C. Detection of micrometastasis in sentinel lymph nodes of patients with primary cutaneous melanoma. Recent Results Cancer Res 2001 158: 137 46.
19. Natsugoe S Mueller J Stein HJ Feith M Hofler H Siewert JR. Micrometastasis and tumor cell microinvolvement of lymph nodes from esophageal squamous cell carcinoma: frequency, associated tumor characteristics, and impact on prognosis. Cancer 1998 83: 858 66.
20. Incarbone R Bonavina L. The prognostic significance of lymph node micrometastasis in patients with esophageal carcinoma. Cancer 1999 86: 1883 5.
21. Mueller JD Stein HJ Oyang T et al. Frequency and clinical impact of lymph node micrometastasis and tumor cell microinvolvement in patients with adenocarcinoma of the esophagogastric junction. Cancer 2000 89: 1874 82.
22. Maehara Y Oshiro T Endo K et al. Clinical significance of occult micrometastasis lymph nodes from patients with early gastric cancer who died of recurrence. Surgery 1996 119: 397 402.
23. Cai J Ikeguchi M Maeta M Kaibara N. Micrometastasis in lymph nodes and microinvasion of the muscularis propria in primary lesions of submucosal gastric cancer. Surgery 2000 127: 32 9.
24. Harrison LE Choe JK Goldstein M Meridian A Kim SH Clarke K. Prognostic significance of immunohistochemical micrometastases in node negative gastric cancer patients. J Surg Oncol 2000 73: 153 7.
25. Cohn DE Folpe AL Gown AM Goff BA. Mesothelial pelvic lymph node inclusions mimicking metastatic thyroid carcinoma. Gynecol Oncol 1998 68: 210 3.
26. Passlick B Pantel K. Detection and relevance of immunohistochemically identifiable tumor cells in lymph nodes. Recent Results Cancer Res 2000 157: 29 37.
27. International (Ludwig)Breast Cancer Study Group. Prognostic importance of occult axillary lymph node micrometastases from breast cancers. Lancet 1990 335: 1565 8.
28. Dowlatshahi K Fan M Bloom KJ Spitz DJ Patel S Snider HC Jr. Occult metastases in the sentinel lymph nodes of patients with early stage breast carcinoma: a preliminary study. Cancer 1999 86: 990 6.
29. Marchiole P Buenerd A Scoazec JY Dargent D Mathevet P. Sentinel lymph node biopsy is not accurate in predicting lymph node status for patients with cervical carcinoma. Cancer 2004 100: 2154 9.
30. Samlal RA van der Velden J. Early cervical carcinoma: how to manage high-risk patients after radical hysterectomy. Eur J Obstet Gynecol Reprod Biol 1999 85: 137 9.
31. Sedlis A Bundy BN Rotman MZ Lentz SS Muderspach LI Zaino RJ. A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: a Gynecologic Oncology Group Study. Gynecol Oncol 1999 73: 177 83.